Invivyd, Inc. Share Price

Invivyd, Inc. Share Price

NASDAQ: IVVD | Micro Cap
$0.60
-$0.02 (-3.07%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Invivyd, Inc. Stock Performance

Open
$0.61
Prev. Close
$0.62
Circuit Range
N/A
Day Range
$0.57 - $0.63
Year Range
$0.53 - $3.05
Volume
81,892
Average Traded
$0.60

Invivyd, Inc. Share Price Today

As of 30 October 2026, Invivyd, Inc.'s share price is $0.60. The stock opened at $0.61, compared to its previous close of $0.62. During today's trading session, Invivyd, Inc.'s share price traded between $0.57 and $0.63, with an average price of $0.60. Over the past 52 weeks, the stock has recorded a high of $3.05 and a low of $0.53. In terms of performance, Invivyd, Inc.'s share price has declined by 57.01% over the last six months and is down 66.14% on a year-on-year basis.

Invivyd, Inc. Share Price Chart

Line chart of the Invivyd, Inc. price trend over the selected period. The price fell overall, ranging from 0.57 to 0.63, ending at 0.60.
$0.57$0.63
L
Show Current Price
H

Invivyd, Inc. Stock Fundamentals & Key Indicators

Market Cap
$102.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.36
Revenue (TTM)
$53.43B
Return On Equity (TTM)
-59.27%
Profit Margin
-98.24%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-323.97%

Invivyd, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$13.13$17.21$13.74$14.29
Net Profit-$10.47-$11.07-$41.40-$44.39
Net Profit Margin-79.74%-64.32%-301.31%-310.64%
Income ChangeN/A-5.73%-273.98%-7.22%

Invivyd, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$25.38$53.43
Net Profit-$241.32-$198.64-$169.93-$52.49
Net Profit MarginN/AN/A-669.54%-98.24%
Income ChangeN/A17.69%14.45%69.11%

About Invivyd, Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Invivyd, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.87
$0.59
-31.60%
Sep 2026
$0.88
$0.86
-4.00%
Aug 2026
$0.55
$0.90
+68.86%
Jul 2026
$0.86
$0.53
-39.36%
Jun 2026
$1.15
$0.88
-23.23%
May 2026
$1.41
$1.15
-17.63%
Apr 2026
$1.32
$1.39
+7.34%
Mar 2026
$1.60
$1.29
-23.60%
Feb 2026
$1.75
$1.70
-2.59%
Jan 2026
$2.48
$1.74
-29.84%
Dec 2025
$2.51
$2.48
+2.06%
Nov 2025
$1.81
$2.43
+37.68%

IVVD Share Price FAQs